(Q53337919)

English

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.

scientific article published on 8 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease. (English)

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Nathan Herrmann

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

Serge Gauthier

2

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

Neli Boneva

3

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

Ole Michael Lemming

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

10158 Investigators

5

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

publication date

8 March 2013

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

International Psychogeriatrics

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

25

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

6

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

919-927

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

Cerebral blood flow in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Severe impairment battery. A neuropsychological test for severely demented patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Donepezil for the treatment of agitation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

21 January 2018

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Agitation in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of behavioral problems in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610213000239

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1041610213000239

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/23472619

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53337919&oldid=1525248930"